Giloy - An Immunity booster without prescription can be harmful

Published On 2022-01-19 10:26 GMT   |   Update On 2022-01-19 10:31 GMT

 Giloy, popularly known as 'Amrita' or 'Guduchi' in Hindi, is an herb that improves digestion and boost immunity.  All parts of the plant are used in Ayurvedic medicine, When the first wave of Covid struck, know-it-all doctors and 'medical experts' claimed that 'giloy' was an immunity booster that would help fight the virus.

 To improve immunity almost overnight, the sales of Giloy rocketed and people started taking it without any medical consultation.

A study recently published in Hepatology Communications, the official journal of the American Association for the Study of Liver Disease, has found that consumption of 'giloy' without prescription and monitoring can cause damage to organs such as the liver. 

For more information check out the full story on the link below: 


Consumption of Too Much Giloy Without Prescription Can be harmful: Study 

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News